Skip to content
PION_Logo_email_sig_300px
Biorelevant-symposium-header-resized

The big mission behind Biorelevant Dissolution

A 1-day symposium to discuss and debate biorelevant assays in Pharmaceutical Science that will bring together scientists who work on formulations that increase the uptake of drugs as well as develop models, instruments, and methods that realistically represent complex biological systems like the GI tract, skin, and others.

Why Attend?

This symposium will bring together scientists who work on formulations that increase the uptake of drugs as well as develop models, instruments,
and methods that realistically represent complex biological systems like the GI tract, skin, and others.

Who should attend?

Scientists who work on formulations that increase the uptake of drugs as well as develop models, instruments, and methods that realistically represent complex biological systems like the GI tract, and skin.

 

 

When and where?

Munich Highlight Towers
Mies-van-der-Rohe-Strasse 6 80807 Munich, Germany
+49 89 1891740

Cocktail reception and networking on June 28 from 6 pm-8 pm (venue TBC)

Seminar/lectures on June 29 from 8 am – 5 pm

Cost

Cost: €475 Industry €375 Academic

To celebrate our return, we will be offering a 20% early bird discount on your registration fee valid through April 28.

 



Confirmed Speakers

Hear from industry leaders at our Biorelevant Symposium. Check back regularly for updates.

Professor Hannah Batchelor

Prof. Hannah Batchelor

University of Strathclyde Glasgow, Strathclyde Institute of Pharmacy and Biomedical Sciences

Stephen_Tindall_Catalent-1

Stephen Tindal

(Advisor) Director, Science & Technology EU & APAC, Catalent Pharma Solutions

Sandra-Klein

Prof. Sandra Klein

University of Greifswald, Department of Pharmacy, Institute of Biopharmaceutics and Pharmaceutical Technology

Thomas-Kipping

Thomas Kipping, PhD

Head of Drug Carriers, Merck KGaA, Darmstadt, Germany

Philippe Berben-1

Philippe Berben, PhD

Scientist Biopharmaceutics, Idorsia Pharmaceuticals Ltd., Basel, Switzerland

Mirko-Koziolek

Mirko Koziolek, PhD

Principal Research Scientist, AbbVie Deutschland GmbH & Co., Germany

Brendan-Griffin

Prof. Brendan Griffin

University College Cork - UCC, School of Pharmacy

Karl-box

Karl Box

Chief Scientific Officer - Europe, Pion UK